Company
Sonoma Biotherapeutics
| Industry | clinical-stage biotechnology company developing engineered regulatory T cell (T reg ) therapies for autoimmune and inflammatory diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Sonoma Biotherapeutics | Investment | 2024-09-04 |